Clinical trialNCT04290676CompletedObservational

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

SponsorEyePoint Pharmaceuticals, Inc.Enrollment527Cataract

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Retrospective study to provide clinical outcomes with DEXYCU (dexamethasone intraocular suspension) 9%.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Dario Paggiarino, MD
Senior Vice President, Chief Medical Officer, EyePoint Pharmaceuticals
Principal Investigator
clinicaltrials.gov ↗
Flavio Leonin, Jr., MD
Senior Manager, Clinical Affairs, EyePoint Pharmaceuticals
Study Director
clinicaltrials.gov ↗
Keyur Patel, PharmD
Vice President, Medical Affairs, EyePoint Pharmaceuticals
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Eye Center South Locations
Dothan, Alabama, United States
Inland Eye Specialists
Hemet, California, United States
Harvard Eye Associates
Laguna Hills, California, United States
Coastal Vision Medical Group
Orange, California, United States
North Bay Eye Associates, Inc.
Rohnert Park, California, United States
the Eye Associates of Manatee, Llp
Bradenton, Florida, United States
Eye Physicians of Pinellas, Pa, Dba the Eye Institute of West Florida
Largo, Florida, United States
Jacksoneye, Sc
Lake Villa, Illinois, United States
Hauser-Ross Eye Institute
Oak Brook, Illinois, United States
Price Vision Group
Indianapolis, Indiana, United States
Physicians Eyecare Center
Baltimore, Maryland, United States
Discover Vision Centers
Independence, Missouri, United States
Silverstein Eye Centers
Kansas City, Missouri, United States
Tekwani Vision Center
St Louis, Missouri, United States
Surgery Center of Central New Jersey
Pennington, New Jersey, United States
Sightmd, Pllc
Hauppauge, New York, United States
New York Eye Surgery Center
The Bronx, New York, United States
Island Eye Surgicenter
Westbury, New York, United States
Wills Surgery Center
Jenkintown, Pennsylvania, United States
Vrf Eye Specialty Group
Memphis, Tennessee, United States
Valley Retina Institute, Pa
McAllen, Texas, United States
the Eye Centers of Racine and Kenosha
Racine, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DEXYCU 9%

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 13 Nov 2019
Primary completion: 1 May 2020
Completion: 1 May 2020
Last update posted: 26 May 2021
Registered enrollment: 527
Registry id: NCT04290676

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.